已收盘 12-19 16:00:00 美东时间
+0.680
+1.96%
vTv Therapeutics Inc. announced that its management team will participate in H.C. Wainwright's "HCW@Home" virtual event on June 12, 2025. The session will feature a fireside chat with key executives discussing the company's development of cadisegliatin, a potential first-in-class oral therapy for type 1 diabetes currently in Phase 3 trials.
06-11 12:00